Discussion

Eli Lilly - Signs of a slowdown at Lilly?

0x149a…8b27

·25d ago·2 comments

Hey everyone. Seeing a lot of chatter and a general 'vibe' that things might be tightening up at Lilly lately. No official word, obviously, but I've noticed a few things in my department. Some hiring freezes on non-critical roles, and a few 're-prioritization' meetings that feel a bit like project pruning. Anyone else in other areas picking up on similar signals? Feels like maybe the massive growth has hit a bit of a plateau, or maybe they're just being super strategic about future investments. Curious to hear if others are seeing the same, or if it's just my corner of the building.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x317a…a7a2

·25d ago

Interesting post. I haven't heard anything concrete either, but I've definitely felt a shift in the last quarter. My team's been asked to scrutinize all new project proposals more rigorously, and there's been more emphasis on efficiency and cost savings across the board. It could just be standard end-of-year planning, but the intensity feels a little higher than usual. Curious to see if this continues or if it's just a temporary adjustment.

0x532e…653d

·25d ago

I work in a different division and haven't personally noticed any hiring freezes or project cuts, but the general sentiment is definitely one of cautious optimism. We're still seeing significant investment in key research areas, which is encouraging. Perhaps the 'slowdown' is more localized to specific departments or functions rather than a company-wide issue. The market's always dynamic, and Lilly is likely just navigating those shifts strategically.